首页|期刊导航|Guideline and Standard in Chinese Medicine|Network pharmacology reveals Moluodan as a potential therapeutic agent for precancerous lesions of gastric cancer

Network pharmacology reveals Moluodan as a potential therapeutic agent for precancerous lesions of gastric cancerOA

中文摘要

Background: Gastric cancer is a leading cause of cancer-related mortality worldwide, and its development often follows a welldefined progression. Traditional Chinese medicine(TCM) formulas, such as Moluodan, have shown potential in preventing the development and progression of gastrointestinal tumors. However, the underlying mechanisms of gastric cancer progression and the specific molecular targets of Moluodan remain unclear. Network medicine, with the ability to analyze complex biological systems,offers a promising approach to address these questions.Methods: We constructed paired disease progression modules(PDPMs) by integrating data from various databases to identify relationships among different stages of gastric cancer, including chronic atrophic gastritis(CAG), intestinal metaplasia(IM), dysplasia(DYS), and gastric cancer(GC). The K-value was calculated to assess the degree of reconstruction between disease-associated modules. Enrichment analysis was performed to validate the identified PDPMs.Results: Our analysis revealed distinct disease-associated networks and highlighted the complex interplay between inflammation,oxidative stress, DNA damage repair, and apoptosis throughout disease progression. We identified several PDPMs associated with Moluodan, suggesting its potential therapeutic targets. Specifically, the overlap between Moluodan targets and PDPMs in the CAGIM transition indicates the efficacy of Moluodan in preventing early-stage development of gastric cancer. Furthermore, our results emphasized the critical roles of interleukin-6(IL-6) and lipid metabolism dysregulation in gastric cancer progression.Conclusions: This study provides new insights into the molecular mechanisms underlying gastric cancer progression. By identifying key PDPMs and their associations with Moluodan, we have highlighted the potential of targeting inflammation, oxidative stress, apoptosis, and lipid metabolism for developing effective prevention and treatment strategies for gastric cancer. Our findings suggest that network medicine can be a powerful tool for understanding complex diseases and identifying novel therapeutic targets.

Yikang Shen;Huaxin Pang;Haiyu Liu;Xiaoping Zhang;Pengzheng Ma;Xiaonan Hu;Mingrui Liu;Qihao Wang;Xiaoxia Xie;Yufeng Zhao

Data Center of Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing,ChinaData Center of Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing,ChinaData Center of Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing,ChinaData Center of Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing,ChinaData Center of Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing,ChinaData Center of Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing,ChinaData Center of Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing,ChinaData Center of Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing,ChinaData Center of Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing,ChinaData Center of Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing,China

医药卫生

gastric cancernetwork medicinemodule reconstruction pairsMoluodan

《Guideline and Standard in Chinese Medicine》 2026 (1)

P.56-62,7

supported by the National Natural Science Foundation of China(No.82374621)

10.1097/gscm.0000000000000088

评论